Physician profile
Danielle Abney
NPI 1134730781
$2,239.70
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.12 · 2022: $784 · 2023: $1,184 · 2024: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,356.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $640.51 | 2021-2024 | Relistor |
| Collegium Pharmaceutical, INC. | $328.84 | 2022-2024 | Belbuca, Xtampza |
| Abbvie INC. | $274.59 | 2022-2024 | Ubrelvy, Qulipta |
| Vertos Medical, INC. | $270.63 | 2022-2024 | Mild Device Kit |
| Almatica Pharma LLC | $184.61 | 2022-2023 | Gralise |
| Ibsa Pharma INC. | $126.76 | 2022-2024 | Tirosint, Licart, Tirosint |
| Grt US Holding, INC. | $96.04 | 2021-2022 | |
| Saluda Medical Americas, INC. | $87.86 | 2023 | Evoke Scs |
| Biohaven Pharmaceutical Holding Company LTD. | $52.43 | 2022 | |
| Averitas Pharma INC. | $36.31 | 2023 | Qutenza |
| Stryker Corporation | $33.03 | 2024 | Mild Device Kit |
| Pfizer INC. | $30.89 | 2023 | |
| Amgen INC. | $24.06 | 2021-2022 | |
| Curonix LLC | $19.78 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $17.00 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.36 | 2023 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Abney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.